Eagle Pharmaceuticals, Inc. - EGRX

SEC FilingsOur EGRX Tweets

About Gravity Analytica

Recent News

  • 10.17.2025 - Annual Stockholder Meeting
  • 10.17.2025 - Annual Stockholder Meeting
  • 10.06.2025 - Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
  • 10.06.2025 - Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
  • 09.17.2025 - Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
  • 09.17.2025 - Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
  • 08.28.2025 - Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
  • 08.28.2025 - Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
  • 08.18.2025 - Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
  • 08.18.2025 - Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

Recent Filings

  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 02.19.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 02.19.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors